Although the scientific relevance in the aforementioned cardiovascular chance factor alterations by tirzepatide are going to be assessed while in the planned cardiovascular final result review SURPASS-CVOT ( "form":"scientific-trial","attrs": "text":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Evaluation i